Please login to the form below

Not currently logged in

severe hypertriglyceridemia

This page shows the latest severe hypertriglyceridemia news and features for those working in and with pharma, biotech and healthcare.

FDA okays Amarin’s Vascepa for cardiovascular risk reduction

FDA okays Amarin’s Vascepa for cardiovascular risk reduction

Amarin’s drug has been approved since 2012 to reduce triglyceride levels in adult patients with severe hypertriglyceridemia, but the new indication makes the drug an option for many millions of

Latest news

  • AZ target Omthera files blood fat drug in US

    FDA submission for Epanova in severe hypertriglyceridemia. Omthera Pharmaceuticals said yesterday it had submitted its drug Epanova for US approval in the treatment of patients with high levels of the blood ... The company, which is the subject of a

  • AstraZeneca offers $443m to buy Omthera AstraZeneca offers $443m to buy Omthera

    In trials, the product has been shown to reduce triglyceride levels and improve other blood lipid profiles and is due to be filed for approval for severe hypertriglyceridemia in the coming

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....